Abbott Laboratories (ABT)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Jan 2, 2016	Jan 3, 2015	Dec 31, 2013	Dec 31, 2012
United States Revenue	17.23B	17.13B	16.32B
United States Revenue Growth	0.62%	4.92%	5.64%
Germany Revenue	-	2.76B	2.54B
Germany Revenue Growth	-	8.67%	8.27%
China Revenue	-	1.91B	2.11B
China Revenue Growth	-	-9.75%	-6.21%
India Revenue	-	1.87B	1.82B
India Revenue Growth	-	2.97%	3.83%
Switzerland Revenue	-	1.87B	1.75B
Switzerland Revenue Growth	-	7.10%	6.65%
Japan Revenue	-	1.48B	1.44B
Japan Revenue Growth	-	2.36%	-4.76%
Netherlands Revenue	-	-	1.12B
Netherlands Revenue Growth	-	-	4.66%
United Kingdom Revenue	-	1.34B	1.19B
United Kingdom Revenue Growth	-	13.08%	19.58%
All Other Countries Revenue	-	15.98B	14.79B
All Other Countries Revenue Growth	-	8.07%	4.98%
Total International Revenue	27.90B	27.20B	25.63B
Total International Revenue Growth	2.57%	6.15%	3.93%
Revenue (Other)	-	-1.34B	-1.19B
Revenue (Total)	45.13B	44.33B	41.95B
Revenue (Total) Growth	1.82%	5.67%	4.59%

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Jan 2, 2016	Jan 3, 2015	Dec 31, 2013	Dec 31, 2012
Established Pharmaceutical Products Revenue	5.70B	5.54B	5.19B
Established Pharmaceutical Products Revenue Growth	3.00%	6.59%	2.53%
Nutritionals Revenue	8.32B	8.45B	8.41B
Nutritionals Revenue Growth	-1.53%	0.45%	3.18%
Diagnostics Revenue	9.06B	8.94B	9.34B
Diagnostics Revenue Growth	1.41%	-4.32%	-6.48%
Medical Devices Revenue	22.03B	21.39B	18.99B
Medical Devices Revenue Growth	3.01%	12.65%	12.43%
Other Segment Revenue	16.00M	17.00M	16.00M
Other Segment Revenue Growth	-5.88%	6.25%	14.29%
Revenue (Total)	45.13B	44.33B	41.95B
Revenue (Total) Growth	1.82%	5.67%	4.59%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Jan 2, 2016	Jan 3, 2015	Dec 31, 2013	Dec 31, 2012
Established Pharmaceutical Products Operating Earnings	1.36B	1.29B	1.23B
Established Pharmaceutical Products Operating Earnings Growth	5.19%	4.62%	2.24%
Nutritionals Operating Earnings	1.48B	1.56B	1.51B
Nutritionals Operating Earnings Growth	-5.33%	3.52%	12.90%
Diagnostics Operating Earnings	1.72B	1.74B	2.07B
Diagnostics Operating Earnings Growth	-1.38%	-16.06%	-14.80%
Medical Devices Operating Earnings	7.50B	7.21B	6.15B
Medical Devices Operating Earnings Growth	3.94%	17.21%	15.96%
Operating Income (Other)	-4.34B	-3.75B	-4.14B
Operating Income (Total)	7.71B	8.05B	6.83B
Operating Income (Total) Growth	-4.32%	17.99%	5.36%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Jan 2, 2016	Jan 3, 2015	Dec 31, 2013	Dec 31, 2012
Organic Sales Growth	5.50%	9.60%

Updated Apr 29, 2026. Data Source: Fiscal.ai.